Literature DB >> 3555786

Hormonal control of human breast cancer cell lines.

R B Dickson, M E Lippman.   

Abstract

The most widely studied steroid hormone responsive cancers are those of the prostate, endometrium and mammary endothelium and the leukaemias. Steroids may in some cases be involved in tumour initiation, and they induce critical events in the malignant 'progression' of these cancers once they develop (after exposure to carcinogens, for example). This paper focuses on the role of the oestrogen receptor as a trigger of cellular growth and invasiveness and as modulator of growth factor secretion in human breast cancer. Growth factor secretion may be a common final pathway of diverse tumorigenic stimuli in a variety of cancers. The finding of external growth control mechanisms suggests possible new ways of therapeutic intervention in breast cancer.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3555786

Source DB:  PubMed          Journal:  Cancer Surv        ISSN: 0261-2429


  4 in total

1.  Irreversible loss of the oestrogen receptor in T47D breast cancer cells following prolonged oestrogen deprivation.

Authors:  J J Pink; M M Bilimoria; J Assikis; V C Jordan
Journal:  Br J Cancer       Date:  1996-10       Impact factor: 7.640

2.  EGF-like ligands mediate progesterone's anti-apoptotic action on macaque granulosa cells.

Authors:  Muraly Puttabyatappa; Rebecca S Brogan; Catherine A Vandevoort; Charles L Chaffin
Journal:  Biol Reprod       Date:  2013-01-25       Impact factor: 4.285

3.  Epidermal growth factor receptor and oestrogen receptors in the non-malignant part of the cancerous breast.

Authors:  S Barker; C Panahy; J R Puddefoot; A W Goode; G P Vinson
Journal:  Br J Cancer       Date:  1989-11       Impact factor: 7.640

4.  Bombesin stimulates proliferation of human breast cancer cells in culture.

Authors:  J Nelson; M Donnelly; B Walker; J Gray; C Shaw; R F Murphy
Journal:  Br J Cancer       Date:  1991-06       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.